Skip to content
DraconiticResearch
Search Sources API
201,818 studies31 sourcesUpdated 26 min ago
Peer-reviewedCC BYFrontiers in cell and developmental biology

HDAC inhibitors in cancer therapy: sensitization mechanisms, combination strategies, and translational challenges

  1. 1Cancer Center, The First Hospital of Jilin University , ,
  2. 2Department of Endocrinology and Metabolism, The First Hospital of Jilin University , , ,
  3. 3School of Medicine, Hebei University of Engineering , ,

Related

  1. Disease-specific gut microbiota–metabolite–immune networks in hematologic disorders: mechanisms, causal support, and translational strategies
    Li Yi, Yuru Yuan, Xiaolong Ma +8
    Gut MicrobesPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationPMC
  2. Overcoming the nuclear barrier in nonviral gene therapy: mechanisms, carrier design, and translational perspectives on NLS peptide and DNA targeting sequence strategies.
    Taegeun Lee, Ye-Rin Kim, Euijin Lee +1
    Drug deliveryPeer-reviewedCC BY-NCFull textMolecular biology & gene regulationEurope PMC
  3. Stem Cell and EV/sEV Strategies for Neuroimmune Niche Reprogramming in Selected CNS Disorders: Mechanisms, Engineered Delivery, and Translational Readiness.
    Wenjing Lu, Junqiang Yan, Hongfang Feng
    CNS neuroscience & therapeuticsPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMC
  4. The vascular–immune interface in breast cancer: normalization strategies, combination therapy, and biomarkers
    Yujing Zhang, Cai Yulan, Kaiguo Long +3
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationCrossrefPMC
  5. Modulating the NLRP3/IL-1β Axis in Age-Related Atherosclerosis: Natural Products, Molecular Mechanisms, and Translational Perspectives—A Narrative Review
    BiomoleculesPeer-reviewedCC BYFull textGeneral biochemistryEurope PMC
BibTeX
@article{liu2026hdac,
  title = {{HDAC inhibitors in cancer therapy: sensitization mechanisms, combination strategies, and translational challenges}},
  author = {Kun-Yao Liu and Xiang Zhao and Jia-Hui Liu and Mu-Nan Li and Hai-Ying Cui and Zhen Wang and Xin Zhou},
  journal = {Frontiers in cell and developmental biology},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13658942},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - HDAC inhibitors in cancer therapy: sensitization mechanisms, combination strategies, and translational challenges
AU  - Kun-Yao Liu
AU  - Xiang Zhao
AU  - Jia-Hui Liu
AU  - Mu-Nan Li
AU  - Hai-Ying Cui
AU  - Zhen Wang
AU  - Xin Zhou
PY  - 2026
DA  - 2026/10/16
JO  - Frontiers in cell and developmental biology
UR  - https://europepmc.org/article/PMC/PMC13658942
SN  - 2296-634X
ER  -